Prostatis Group
Prostatis Group reported 190 stocks worth $429M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are THIR (16.8%), DIVO (4.9%) and QQQ (3.9%). Compared with Q1 2026, the fund opened new positions in PWB, SPCX and ACYN, added to VUG, BIL and IAI, trimmed THIR, DIVO and QQQ and sold out of IYG, XAR and ITB.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  THIR Thor Finl Technologies TR | $72.1M | 16.8% | 2.1M | −28K (−1%) | 8 of 8 | |
| 2 |  DIVO Amplify ETF TR | $20.9M | 4.9% | 457K | −12K (−3%) | 8 of 8 | |
| 3 |  QQQ Invesco Qqq TR | $16.6M | 3.9% | 22K | −5,628 (−20%) | 8 of 8 | |
| 4 |  VUG Vanguard Index Fds | $12M | 2.8% | 139K | +115K (+490%) | 8 of 8 | |
| 5 |  IGM Ishares TR | $11.6M | 2.7% | 71K | −15K (−17%) | 6 of 8 | |
| 6 |  AIED Exchange Listed Fds TR | $11.5M | 2.7% | 179K | −51K (−22%) | 8 of 8 | |
| 7 |  XNTK Spdr Series Trust | $10.3M | 2.4% | 26K | −11K (−30%) | 4 of 8 | |
| 8 |  IYW Ishares US Technology | $9.1M | 2.1% | 36K | −4,055 (−10%) | 8 of 8 | |
| 9 |  PWB Invesco Exchange Traded FD T | $9M | 2.1% | 54K | New position | 1 of 8 | |
| 10 |  BIL ST Stert Spdr Blmbg 1 3 | $8.4M | 2.0% | 92K | +43K (+87%) | 8 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 IYG Ishares US Financial Seretf | $4M | 48K |
 XAR Spdr Series Trust | $3.4M | 14K |
 ITB Ishares TR | $2M | 23K |
 NFLX Netflix Inc | $1M | 11K |
 PLTR Palantir Technologies Inc | $568K | 3,882 |
🔒 Free account: see all 16.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Prostatis Group 13F FAQ
What does Prostatis Group own?
Prostatis Group reported 190 stocks worth $429M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are THIR (16.8%), DIVO (4.9%) and QQQ (3.9%). The table above lists every position in the filing (the top 10 without an account).
What did Prostatis Group buy and sell in Q2 2026?
Compared with Q1 2026: 39 new positions, 61 added to, 81 trimmed and 16 sold out. New positions include PWB, SPCX and ACYN. It sold all of IYG, XAR and ITB.
When will Prostatis Group file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Prostatis Group's portfolio worth?
The Q2 2026 filing reports $429M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.